Iambic Therapeutics (IAM) Financials: Revenue & Earnings

IAM price $14.71 +0.71 +5.07%

Ticker
IAM
Price
$14.71
Change
+0.71 +5.07%
Market cap ?
$137.91M
Sector
Healthcare
Industry
Biotechnology

Fair value

IAM fair value Not meaningful. Price $14.71.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare IAM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
No data yet.

Dividends

Yield —. Payout ratio —. Frequency —.

Safety score 34/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. Yield is unknown, so this part stays neutral.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-16Catalio Capital Management, LPBuy2.00M——
2026-10-16Catalio Capital Management, LPBuy1.46M——
2026-10-16Catalio Capital Management, LPBuy742.55K$16.0011.88M
2026-10-16Catalio Capital Management, LPSell1.14M——
2026-10-16Catalio Capital Management, LPSell731.19K——
2026-10-16Catalio Capital Management, LPSell122.68K——
2026-10-16Catalio Capital Management, LPSell1.46M——
2026-10-16Catalio Capital Management, LPSell742.55K——
2026-10-16Vogelstein R JacobBuy2.00M——
2026-10-16Vogelstein R JacobBuy1.46M——
2026-10-16Vogelstein R JacobBuy742.55K$16.0011.88M
2026-10-16Vogelstein R JacobSell1.14M——
2026-10-16Vogelstein R JacobSell731.19K——
2026-10-16Vogelstein R JacobSell122.68K——
2026-10-16Vogelstein R JacobSell1.46M——
2026-10-16Vogelstein R JacobSell742.55K——
2026-10-16Secora MichaelBuy61.34K——
2026-10-16Secora MichaelSell61.34K——
2026-10-16RASTETTER WILLIAM HBuy8.34K$16.00133.46K
2026-10-16RASTETTER WILLIAM HBuy192.58K——
2026-10-16RASTETTER WILLIAM HSell36.80K——
2026-10-16RASTETTER WILLIAM HSell14.97K——
2026-10-16RASTETTER WILLIAM HSell8.34K——
2026-10-16RASTETTER WILLIAM HSell76.80K——
2026-10-16RASTETTER WILLIAM HSell64.00K——
2026-10-16Rachlin Evan LockwoodBuy718.75K$16.0011.50M
2026-10-16Rachlin Evan LockwoodBuy410.76K$16.006.57M
2026-10-16Rachlin Evan LockwoodBuy1.46M——
2026-10-16Rachlin Evan LockwoodBuy57.75K——
2026-10-16Rachlin Evan LockwoodSell57.75K——
2026-10-16Rachlin Evan LockwoodSell306.71K——
2026-10-16Rachlin Evan LockwoodSell410.76K——
2026-10-16Catalio Capital Management, LPOther742.55K——
2026-10-16Vogelstein R JacobOther742.55K——
2026-10-16RASTETTER WILLIAM HOther8.34K——
2026-10-16Rachlin Evan LockwoodOther410.76K——
2026-10-14EMSTER KURT VONBuy20.30K$16.00324.80K
2026-10-14Vogelstein R JacobBuy20.30K$16.00324.80K
2026-10-14TAGLIAFERRI MARYBuy20.30K$16.00324.80K
2026-10-14Sharp ShaliniBuy20.30K$16.00324.80K
2026-10-14RASTETTER WILLIAM HBuy40.60K$16.00649.60K
2026-10-14Rachlin Evan LockwoodBuy20.30K$16.00324.80K
2026-10-14Secora MichaelBuy28.40K——
2026-10-14Secora MichaelBuy170.30K$16.002.72M
2026-10-14Olson Peter ABuy116.90K$16.001.87M
2026-10-14Olson Peter ABuy19.50K——
2026-10-14Josephson NeilBuy185.90K$16.002.97M
2026-10-14Josephson NeilBuy31.00K——
2026-10-14Manby Frederick RBuy132.20K——
2026-10-14Manby Frederick RBuy793.20K$16.0012.69M
2026-10-14Miller Thomas F.Buy132.20K——
2026-10-14Miller Thomas F.Buy793.20K$16.0012.69M
2026-10-14Catalio Capital Management, LPOther731.19K——
2026-10-14Catalio Capital Management, LPOther1.14M——
2026-10-14Catalio Capital Management, LPOther122.68K——
2026-10-14Catalio Capital Management, LPOther1.46M——
2026-10-14EMSTER KURT VONOther0——
2026-10-14Vogelstein R JacobOther1.14M——
2026-10-14Vogelstein R JacobOther731.19K——
2026-10-14Vogelstein R JacobOther122.68K——
2026-10-14Vogelstein R JacobOther1.46M——
2026-10-14TAGLIAFERRI MARYOther66.56K$6.47430.62K
2026-10-14Sharp ShaliniOther66.56K$8.73581.03K
2026-10-14RASTETTER WILLIAM HOther76.80K——
2026-10-14RASTETTER WILLIAM HOther64.00K——
2026-10-14RASTETTER WILLIAM HOther36.80K——
2026-10-14RASTETTER WILLIAM HOther14.97K——
2026-10-14RASTETTER WILLIAM HOther66.56K$3.00199.67K
2026-10-14Rachlin Evan LockwoodOther57.75K——
2026-10-14Rachlin Evan LockwoodOther306.71K——
2026-10-14Hirawat SamitOther66.56K$12.47829.95K
2026-10-14Secora MichaelOther0——
2026-10-14Secora MichaelOther61.34K——
2026-10-14Secora MichaelOther190.16K$7.311.39M
2026-10-14Secora MichaelOther9.51K$8.7383.00K
2026-10-14Olson Peter AOther0——
2026-10-14Olson Peter AOther204.58K$7.311.50M
2026-10-14Olson Peter AOther57.05K$8.73498.03K
2026-10-14Josephson NeilOther0——
2026-10-14Josephson NeilOther175.53K$4.95868.89K
2026-10-14Josephson NeilOther57.05K$8.73498.03K
2026-10-14Manby Frederick ROther0——
2026-10-14Manby Frederick ROther39.08K$3.00117.25K
2026-10-14Manby Frederick ROther137.70K$6.47890.90K
2026-10-14Manby Frederick ROther136.03K$8.731.19M
2026-10-14Manby Frederick ROther317.39K——
2026-10-14Miller Thomas F.Other0——
2026-10-14Miller Thomas F.Other137.70K$6.47890.90K
2026-10-14Miller Thomas F.Other136.03K$8.731.19M
2026-10-14Miller Thomas F.Other317.39K——
2017-10-17Herrmann William H JrOther0——

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

Iambic Therapeutics Inc. (IAM) trades at $14.71, with a market cap of $137.91M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Iambic Therapeutics (IAM) Financials: Revenue & Earnings

IAM$14.71+0.71 +5.07%

$137.91M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History